-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Stoke Therapeutics, Maintains $22 Price Target

Benzinga·03/18/2025 15:50:45
Listen to the news
Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $22 price target.